DOI: 10.1002/cncr.30850, Received: April 25, 2017; Revised: May 24, 2017; Accepted: May 25, 2017,
Published online Month 00, 2017 in Wiley Online Library (wileyonlinelibrary.com)
Pembimbing:
dr. Heru Purwanto, M.Sc., SpB (K) Onk
1
terhadap efek toksisitas. Study ini menyajikan evaluasi mengenai penambahan
adjuvant CRT sebagai terapi terapi kanker nasofaring. Berdasarkan uraian
tersebut, kami tertarik untuk mencari evidence lebih jauh dengan melakukan
telaah jurnal ini.
Patient / Intervention/
Problem / Indicator/ Comparison Outcome
Population Index
Pada pasien Yang mendapatkan Yang Dapat
Regionally Concurrent- mendapatkan meningkatkan
Advanced adjuvant radioterapi saja angka survival
Nasopharyngeal chemoterapy
Carcinoma
Penulis:
Anne W. M. Lee, MD 1; Stewart Y. Tung, FRCR2; Wai Tong Ng, MD3;
Victor Lee, MD1; Roger K. C. Ngan, FRCR4; Horace C.W. Choi, PhD1;
Lucy L. K. Chan, BSc3; Lillian L. Siu, MD5; Alice W. Y. Ng, FRCR2; To
2
Wai Leung, MD6; Harry H. Y. Yiu, FRCR4; Brian O’Sullivan, MD5; and
Rick Chappell, PhD7
Judul:
A Multicenter, Phase 3, Randomized Trial of Concurrent
Chemoradiotherapy Plus Adjuvant Chemotherapy Versus Radiotherapy
Alone in Patients With Regionally Advanced Nasopharyngeal Carcinoma:
10-Year Outcomes for Efficacy and Toxicity
Nama & Tahun Jurnal:
Cancer Month 00, 2017
3
VI. Relevansi PICO Pertanyaan Klinis dengan PICO Jurnal
“Non-keratinizing (differentiated or
undifferentiated) carcinoma of the
nasopharynx, as classified by the World
Health Organization system, and T1-
4/N2-3/M0 disease, as classified by the
TNM system (5th edition). “
4
dengan yang mendapatkan radioterapi
saja.
5
rate (LR-FFR), and distant failure-free
rate (D-FFR). The secondary endpoints
for safety included major toxicities
(except for xerostomia and dental caries)
of grade 3 or higher; the current article
is focused on late toxicities. For patients
who had re irradiation for the treatment
of locoregional relapses, events were
censored at the commencement of re-
irradiation so that toxicities incurred
solely by the primary treatment could be
assessed.”
ABSTRACT
RESULTS:
“The early findings of significant
improvements in tumor control were
maintained: the CRTgroup achieved
significantly higher 10-year overall
failure-free (62% vs 50%; P 5 .01) and
progression-free survival rates (56% vs
42%; P 5 .006) because of superior
locoregional control (87% vs 74%; P 5
.003), whereas the impact on distant
control remained insignificant (68% vs
65%; P 5 .24). The initial differences in
toxicities diminished with longer follow-
up: 52% versus 47% at 10 years for late
toxicities (P 5 .20), 4.1% versus 2.8% for
deaths due to treatment toxicity, and
15.1% versus 13.1% for deaths due to
incidental/unknown causes. The OS rate
for the CRT group reached statistical
superiority at 10 years (62% vs 49%; P 5
.047).
CONCLUSIONS: Long-term
results have confirmed that CRT can
significantly improve OS without
excessive late toxicities for patients with
regionally advanced NPC.”
6
VIII. Telaah Kritis Jurnal yang Diperoleh.
Validity
Telaah Validity Jawaban
Worksheet (beri tanda untuk yang anda sesuai
RAMMBO pilih) Worksheet
Prognosis √
7
2. Allocation Bagaimana pasien Ya√
diperlakukan? Jika ada Tidak
subkelompok dengan Tidak jelas
prognosis berbeda,
apakah dilakukan Pembagian kelompok dilakukan
penyesuaian untuk faktor secara random. Sub grup dibagi
prognosis yang penting? menjadi stadium III dan stadium
IV B, kedua grup mendapatkan
karakteristik, tumor factor, dan
RT parameter yang sama.
RESULTS
The 2 treatment groups were
well balanced in all patient
characteristics, tumor factors,
and RT parameters. Four
patients had major protocol
violations (Fig. 1): 2 patients
(1.2%) in the CRT group did not
receive chemotherapy, and 2
patients (1.1%) in the RT group
received chemotherapy. The
compliance with chemotherapy
in the CRT group has been
described in a previous report.6
8
3. Maintenance Apakah status kelompok Ya √
dipertahankan tetap
sebanding dengan Pasien dari kedua kelompok
manajemen yang sama? dilakukan terapi sinar yang
......... dan follow up yang sama, yaitu dengan megavoltage
memadai? photons dan dengan dosis sesuai
ketentuan masing-masing
tempat.
Pengobatan lanjutan diberikan
kepada pasien yang mengalami
relaps.
Dikutip dari:
MATERIALS AND
METHODS
Assasment and Treatment
9
related late toxicities were
graded according to the Late
Radiation Morbidity Scoring
Criteria of the Radiation
Therapy Oncology Group.
RESULTS
Efficacy
Dikutip dari:
MATERIALS AND
METHODS
Study Design and Patients
10
CRT group). Randomization
was generated by the consulting
statistician in sealed envelopes
labeled by the stratum; they
were unsealed only after patient
registration. Treatment
allocation was not masked, but
the statisticians were blinded.
Importancy
Telaah Importancy Jawaban sesuai
Worksheet (beri tanda untuk yang anda pilih) Worksheet
Prognosis
Apakah Dari analisa subgrup didapatkan hasil yang baik pada akhir
kemaknaan kedua kelompok dengan tambahan kemoterapi. Untuk besarnya
statistik & penurunan resiko bahaya lebih besar pada stage III.
kemaknaan klinis Secara keseluruhan terdapat 132 kali kemunculan dari toksisitas
dari hasil derajat 3 dan yang lebih tinggi. Toksisitas derajat III lebih tinggi
penelitian pada kelompok CRT selama 3 tahun pertama.
tergambar dengan
baik?
Pengukuran apa HR
yang digunakan
dan seberapa
11
dampak Kemaknaan statistik dan klinis tergambar di bawah ini, dengan nilai
perlakuannya? p p< 0.001, HR 0,71; 95% CI (0,55-0,99)
(PR, OR, RR, HR
?)
Mungkinkah Tidak terjadi karena kebetulan. Penelitian ini memiliki nilai p <
dampak terjadi 0.001, di mana menunjukkan bahwa probabilitas yang
karena kebetulan? menunjukkan faktor kebetulan rendah, di dukung dengan 95% CI
P-value ? (0,64-0,89) tidak mengandung angka 1
Interval
kepercayaan (CI)?
12
Applicability
IX. Kesimpulan
13